More and more workers are using weight loss drugs. It’s costing their employers a fortune – CNN
More and more workers are using weight loss drugs. It’s costing their employers a fortune CNN Ozempic for All The Atlantic Lopez: Expanding access to anti-obesity drugs a win-win Boston Herald What To Do When Insurance Won’t Cover Your GLP-1 Prescription NewBeauty Perspectives from Employers on the Costs and Issues Associated with Covering GLP-1 Agonists for Weight Loss KFF
Coke Is Leaning Into the Protein Craze as It Lands in More Drinks, Snacks—and Pet Foods
Beata Zawrzel / NurPhoto via Getty Images Coca-Cola is ramping up production of high-protein milks. Key Takeaways Coca-Cola is leaning into its high-protein milk products, but also planning to shake up the segment’s offerings as competition in the space heats up. Many food and beverage companies are focused on protein as a greater share of […]
GLP-1 Drugs Tied to Lower Risk of Legal Blindness in People With Diabetes
(MedPage Today) — ORLANDO — Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective cohort study linked GLP-1 receptor agonists to a lower risk of legal blindness in patients with type 2…
Healthy Returns: A key step forward for Novo Nordisk’s GLP-1 pill
A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives Trump credit on drug prices.
GLP-1 Drugs May Manage Weight Recurrence After Bariatric Surgery
Glucagon-like peptide-1 (GLP-1) receptor agonists may support weight management in patients following bariatric surgery. A study suggests that GLP-1 drug use is particularly common among those with less postsurgical weight loss.
NVO’s Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients
Novo Nordisk NVO received FDA approval for a regulatory application seeking the label expansion of its oral GLP-1 drug, Rybelsus (semaglutide), to include cardiovascular (CV) risk reduction in adults with type II diabetes (T2D). This approval makes Rybelsus the first and only oral GLP-1 therapy approved to lower the risk of major adverse cardiovascular events (MACE), […]
Study finds GLP-1 drugs may help prevent risks from sleep apnea
GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, researchers wrote in a new study.
American Airlines Drops Ozempic Coverage, Flight Attendants Push Back
Ozempic may still be flying high in America, but not in American Airlines’ employee health plan. American Airlines Cuts Ozempic From Flight Attendant Healthcare Coverage Starting January 1, 2026, American Airlines flight attendants will lose insurance coverage for popular GLP-1 medications such as Ozempic and Mounjaro, unless they have a formal diagnosis of Type 2 […]
GLP-1 Drugs Help Protect Against Sleep Apnea, Study Says
By Dennis Thompson HealthDay ReporterTUESDAY, Oct. 21, 2025 (HealthDay News) — Weight-loss drugs like Ozempic and Zepbound might help protect…
Did Eli Lilly Just Say “Checkmate” to Novo Nordisk?
Key Points Though Novo Nordisk had a first-mover advantage in the GLP-1 market, Eli Lilly is catching up. Lilly’s recent clinical progress sets it up for another critical approval. The company has fantastic medium-term prospects. 10 stocks we like better than Eli Lilly › Novo Nordisk (NYSE: NVO), a Denmark-based drugmaker, was a pioneer in […]